The urinary tract is one of the most common sites for adult bacterial infections, particularly for post-menopausal and elderly women. The use of quantitative PCR technology accurately captures and quantifies the microbiota of the urinary tract providing an important clinical assessment tool for those experiencing complicated urinary tract infections (UTI).
Extending beyond the bladder to the kidneys, complicated UTI’s are considered more serious than their uncomplicated counterpart, which is usually confined to the bladder and urethra.
Recurring UTI’s can lead to numerous complications including kidney damage, premature birth, low birth weight, and in serious cases sepsis.
We use real-time polymerase chain reaction (RT-PCR) tests to qualitatively detect nucleic acid from various parasites, bacteria, and viruses. The RT-PCR platform is FDA-authorized and requires specialized equipment and personnel to identify DNA within cells. Polymerase chain reaction (PCR) is a relatively simple and widely used molecular biology technique to amplify and detect DNA and RNA sequences.
The use of PCR testing allows US BioTek to more precisely identify even the smallest amounts of markers within the urine sample providing accurate, reliable, and reproducible results.